Specialists in protease inhibitor design, and nucleoside- and nucleotide science. Medivir’s strategy is to apply our scientific expertise to the area of oncology to develop innovative anti-cancer drugs.
The wheel illustrates how our clinical- and early research projects align with the hallmarks of cancer.
we continuously evaluate new oncology projects. Criteria assessed for a new project to be included: